Event Brief
Celltrion's Truxima Dominates U.S. Prescription Market
Filed: Apr 06, 2026 at 10:07 PM ET
Summary: Celltrion's Truxima leads the U.S. prescription market as of February 2026.
WHO: Celltrion Inc.
WHAT: Truxima leads U.S. prescription market
WHEN: Apr 06, 2026 at 9:46 PM ET
WHERE: USA
WHY: No specific cause was reported.
ℹ️ This event is analyzed using pattern arcs, velocity indicators, and source analysis in our MI Console.
Know more. Read less.
The BriefBrief follows the story, so you don't have to read every article. See what happened, how it changed, and where it came from, all in one place.
Same format. Every time.
See how stories unfold →